Lixisenatide Subcutaneous and Peginterferon Alfa-2b (Peg-Intron)
Determining the interaction of Lixisenatide Subcutaneous and Peginterferon Alfa-2b (Peg-Intron) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: Peginterferon alfa-2b, Peginterferon Alfa-2b
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Peginterferon Alfa-2b (Sylatron)
- Lixisenatide Subcutaneous-Peginterferon alfa-2b Subcutaneous
- Lixisenatide Subcutaneous-Peginterferon beta-1a
- Lixisenatide Subcutaneous-Peginterferon beta-1a Subcutaneous
- Lixisenatide Subcutaneous-PegIntron
- Lixisenatide Subcutaneous-Pegloticase
- Peginterferon Alfa-2b (Peg-Intron)-Lixtraxen Injection
- Peginterferon Alfa-2b (Peg-Intron)-LMD
- Peginterferon Alfa-2b (Peg-Intron)-LMD Injection
- Peginterferon Alfa-2b (Peg-Intron)-LMX 4 Topical application
- Peginterferon Alfa-2b (Peg-Intron)-LMX 5
- Peginterferon Alfa-2b (Peg-Intron)-LMX 5 Topical application